AlphaCore Pharma

Founded by renowned scientists and entrepreneurs from both industry and academia. Over the past few years, our team has been dedicated to researching the role of the microbiome in health and disease. Recently, we have expanded our interests to the emerging field of pharmaceutical biomics. Given the significant variability in clinical responses to drugs, we recognize the need for better and more personalized predictive patient care, as well as the opportunity to leverage the microbiome for safer and more effective drug therapies. We have embarked on this journey with AlphaBiomics, whose mission is to develop microbiome-based precision medicine solutions to predict drug responses and improve therapeutic outcomes. Developing microbiome-based predictive diagnostics and companion therapeutics to enable safer and more effective drug treatments.